Trial Profile
Safety and efficacy of intradetrusor onabotulinum toxin A injections for the treatment of overactive bladder in patients with Parkinson's disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2019
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- 27 Sep 2018 New trial record
- 31 Aug 2018 Results presented at the 48th Annual Meeting of the International Continence Society